How many institutions held CHRS - Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share in Q2 2023?

159 institutional investors reported CHRS - Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share for Q2 2023. Use the holders table for investor-level position and value details.

Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS)

Q: What does CUSIP 19249H103 represent in this 13F holders report?

CUSIP 19249H103 is the security identifier for CHRS - Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share used to aggregate holder disclosures.

CUSIP: 19249H103

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class: Equity / Common Stock, $0.0001 par value per share
Shares outstanding: 153,624,096
Total 13F shares: 86,685,207
Share change: +8,699,408
Total reported value: $370,290,994
Put/Call ratio: 137%
Price per share: $4.27
Number of holders: 159
Value change: +$30,644,927
Number of buys: 97
Number of sells: 70

Quarterly Holders Quick Answers

What is CUSIP 19249H103?
CUSIP 19249H103 identifies CHRS - Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2023
Previous quarter: Q1 2023

Recent filing periods for CUSIP 19249H103:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of CHRS - Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	9.4%	14,397,565	$98,479,343	—	31 Mar 2023	13F
Temasek Holdings (Private) Ltd	13F	Company	4.8%	7,381,116	$50,486,833	—	31 Mar 2023	13F
ALLIANCEBERNSTEIN L.P.	13F	Company	4%	6,136,925	$41,976,567	—	31 Mar 2023	13F
STATE STREET CORP	13F	Company	4%	6,097,583	$41,707,468	—	31 Mar 2023	13F
JPMORGAN CHASE & CO	13F	Company	3.9%	5,982,535	$40,920,000	—	31 Mar 2023	13F
VANGUARD GROUP INC	13F	Company	3.8%	5,857,200	$40,063,248	—	31 Mar 2023	13F
Kohlberg Kravis Roberts & Co. L.P.	13F	Company	2%	3,036,076	$20,766,762	—	31 Mar 2023	13F
Aristotle Capital Boston, LLC	13F	Company	1.5%	2,254,102	$15,418,060	—	31 Mar 2023	13F
CITADEL ADVISORS LLC	13F	Company	0.97%	1,496,903	$10,238,816	—	31 Mar 2023	13F
AMERIPRISE FINANCIAL INC	13F	Company	0.89%	1,367,820	$9,355,886	—	31 Mar 2023	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.85%	1,308,370	$8,949,250	—	31 Mar 2023	13F
DISCIPLINED GROWTH INVESTORS INC /MN	13F	Company	0.76%	1,165,512	$7,972,102	—	31 Mar 2023	13F
PEREGRINE CAPITAL MANAGEMENT LLC	13F	Company	0.69%	1,067,184	$7,299,539	—	31 Mar 2023	13F
D. E. Shaw & Co., Inc.	13F	Company	0.65%	998,378	$6,828,905	—	31 Mar 2023	13F
C WorldWide Group Holding A/S	13F	Company	0.6%	928,464	$6,351,000	—	31 Mar 2023	13F
CITIGROUP INC	13F	Company	0.57%	869,313	$5,946,101	—	31 Mar 2023	13F
PICTET ASSET MANAGEMENT SA	13F	Company	0.56%	854,258	$5,843,125	—	31 Mar 2023	13F
NORTHERN TRUST CORP	13F	Company	0.5%	763,668	$5,223,490	—	31 Mar 2023	13F
SEI INVESTMENTS CO	13F	Company	0.48%	736,519	$5,037,790	—	31 Mar 2023	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.44%	677,030	$4,630,885	—	31 Mar 2023	13F
SCOUT INVESTMENTS, INC.	13F	Company	0.42%	650,950	$4,452,498	—	31 Mar 2023	13F
MARSHALL WACE, LLP	13F	Company	0.37%	572,928	$3,918,828	—	31 Mar 2023	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.37%	567,374	$3,880,839	—	31 Mar 2023	13F
Bank of New York Mellon Corp	13F	Company	0.37%	560,900	$3,836,556	—	31 Mar 2023	13F
PLATINUM INVESTMENT MANAGEMENT LTD	13F	Company	0.36%	549,899	$3,761,309	—	31 Mar 2023	13F
JACOBS LEVY EQUITY MANAGEMENT, INC	13F	Company	0.34%	519,505	$3,553,414	—	31 Mar 2023	13F
MORGAN STANLEY	13F	Company	0.33%	509,344	$3,483,914	—	31 Mar 2023	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.33%	505,242	$3,455,855	—	31 Mar 2023	13F
MACQUARIE GROUP LTD	13F	Company	0.28%	430,000	$2,941,000	—	31 Mar 2023	13F
CREDIT SUISSE AG/	13F	Company	0.27%	410,268	$2,806,233	—	31 Mar 2023	13F
PRINCIPAL FINANCIAL GROUP INC	13F	Company	0.26%	402,452	$2,752,772	—	31 Mar 2023	13F
Rafferty Asset Management, LLC	13F	Company	0.26%	400,569	$2,739,892	—	31 Mar 2023	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.25%	378,920	$2,591,813	—	31 Mar 2023	13F
LAZARD ASSET MANAGEMENT LLC	13F	Company	0.25%	377,333	$2,580,000	—	31 Mar 2023	13F
BNP PARIBAS FINANCIAL MARKETS	13F	Company	0.24%	374,493	$2,561,532	—	31 Mar 2023	13F
AlphaCentric Advisors LLC	13F	Company	0.23%	354,500	$2,424,780	—	31 Mar 2023	13F
Invesco Ltd.	13F	Company	0.18%	282,145	$1,929,871	—	31 Mar 2023	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.14%	218,474	$1,494,000	—	31 Mar 2023	13F
BALYASNY ASSET MANAGEMENT L.P.	13F	Company	0.14%	217,045	$1,484,588	—	31 Mar 2023	13F
RHUMBLINE ADVISERS	13F	Company	0.13%	205,773	$1,407,000	—	31 Mar 2023	13F
UBS Group AG	13F	Company	0.13%	205,412	$1,405,018	—	31 Mar 2023	13F
KENNEDY CAPITAL MANAGEMENT LLC	13F	Company	0.13%	202,506	$1,385,141	—	31 Mar 2023	13F
CM Management, LLC	13F	Company	0.13%	200,000	$1,368,000	—	31 Mar 2023	13F
TANG CAPITAL MANAGEMENT LLC	13F	Company	0.13%	200,000	$1,368,000	—	31 Mar 2023	13F
BARCLAYS PLC	13F	Company	0.12%	188,516	$1,289,449	—	31 Mar 2023	13F
Nuveen Asset Management, LLC	13F	Company	0.11%	175,659	$1,202,000	—	31 Mar 2023	13F
Bridge City Capital, LLC	13F	Company	0.11%	166,086	$1,136,028	—	31 Mar 2023	13F
Phocas Financial Corp.	13F	Company	0.11%	163,140	$1,116,000	—	31 Mar 2023	13F
Cubist Systematic Strategies, LLC	13F	Company	0.1%	159,414	$1,090,392	—	31 Mar 2023	13F
STATE OF WISCONSIN INVESTMENT BOARD	13F	Company	0.1%	158,890	$1,086,808	—	31 Mar 2023	13F

Institutional Holders of Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS) as of Q2 2023

As of 30 Jun 2023, Coherus Oncology, Inc. - Common Stock, $0.0001 par value per share (CHRS) was held by 159 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 86,685,207 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, Temasek Holdings (Private) Ltd, CITADEL ADVISORS LLC, JPMORGAN CHASE & CO, Kohlberg Kravis Roberts & Co. L.P., MORGAN STANLEY, STATE STREET CORP, Aristotle Capital Boston, LLC, and MARSHALL WACE, LLP. This page lists 159 institutional shareholders reporting positions in this security for the Q2 2023 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2023 vs Q1 2023 Across Filers

Q1 2023 holders

163

Q2 2023 holders

159

Holder diff

-4

Investor	Q1 2023 Shares	Q2 2023 Shares	Share Diff	Share Chg %	Q1 2023 Value $	Q2 2023 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.